THE EFFECT OF SULPIRIDE IN IMPROVING QUALITY OF LIFE OF PATIENTS WITH IRRITABLE BOWEL SYNDROME

Võ Duy Thông, Nguyễn Ngọc Phúc

Main Article Content

Abstract

Background: Irritable bowel syndrome (IBS) is a chronic gastrointestinal disease associated with bowel dysfunction, which can significantly impact the quality of life (QoL) of patients. Objectives: To investigate the effect of sulpiride in improving quality in patients with IBS by ROME III criteria at University Medical Center. Methods: We conducted a cross-sectional study in patients diagnosed with IBS at the Gastroenterology clinic of University Medical Center from 01st June, 2018 to 1st February, 2019, indicated with or without sulpiride. The data of patient informations were collected, the QoL of patients was accessed based on validated Vietnamese version IBS-QoL questionnaire for all participants at the baseline. and after 8 weeks of follow-up. Results: After 8 weeks of follow-up, 246 patients completed the study, of which 120 patients used sulpiride and 126 patients did not use sulpiride, the female / male ratio was 1.4/1. After 8 weeks of follow-up, the overall IBS-QoL score and the domains of IBS-QoL in irritability, health anxiety, social response, and relationship in sulpiride group were statistically significantly higher than those in the non-sulpiride group. (p <0.001). The change in IBS-QoL score, the change in domain of discomfort, obstruction of performance, fitness, health anxiety, social reactions, and relationship in the sulpiride group were also higher than these in non-sulpiride group (p < 0.05). Conclusion: The use of sulpiride in the treatment of IBS patients improved overall QoL score, especially changes in the domain of uncomfortable characteristics, impeded performance, physical fitness, health anxiety, social reactions, relationships.

Article Details

References

1. Canavan C. et al. The epidemiology of irritable bowel syndrome. Clinical epidemiology. 2014. 6:71.
2. Võ Thị Thuý Kiều, Bùi Thị Hương Quỳnh, Võ Duy Thông. Khảo sát việc điều trị hội chứng ruột kích thích tại bệnh viện Nhân Dân Gia Định. Tạp chí Y học TP. Hồ Chí Minh. 2015. 19: 760-765.
3. Agarwal N, Spiegel BM. The effect of irritable bowel syndrome on health-related quality of life and health care expenditures. Gastroenterology Clinics. 2011; 40(1):11-19
4. Doan Phan Ngoc Thao, Nguyen Ngoc Phuc, Vo Duy Thong, Bui Thi Huong Quynh. Investigation of quality of life and factors related to quality of life of patients with irritable bowel syndrome. Vietnam Journal of Medicine and Pharmacy. 2018. 23(2):227-233.
5. Jarrett ME, Cain KC, Burr RL, et al. Comprehensive self-management for irritable bowel syndrome: Randomized trial of in-person versus combined in-person and telephone sessions. The American Journal of Gastroenterology. 2009. 104(12):3004
6. Schneider A, Rosenberger S, Bobardt J. Self-help guidebook improved quality of life for patients with irritable bowel syndrome. PloS One. 2017. 12(7): e0181764.
7. Dorn SD, Palsson OS, Woldeghebriel M, et al. Development and pilot testing of an integrated, web‐based self‐management program for irritable bowel syndrome (IBS). Neurogastroenterology & Motility. 2015; 27(1):128-134.